Genevieve Bouchard-Fortier MD FRCPC MSc
Gynecologic Oncologist, University Health Network
Assistant Professor
Obstetrics & Gynecology
Temerty Faculty of Medicine, University of Toronto
Sarah E. Ferguson MD FRCSC
Phyllis Glanc MD FRCPC FACR FSRU FAIUM (she/her)
Vice-Chair, Continuing Professional Development (CPD), Medical Imaging, University of Toronto
Associate Scientist, Sunnybrook Research Institute
Department of Medical Imaging, Body Division
Sunnybrook Health Sciences Centre
Professor of Radiology, Obstetrics & Gynecology
Temerty Faculty of Medicine, University of Toronto
Kathy Han MD MScFRCPC
Gynecologic Radiation Oncology Lead, Princess Margaret Cancer Centre
University Health Network
Associate Professor, Department of Radiation Oncology
Temerty Faculty of Medicine, University of Toronto
Anjelica Hodgson MD FRCPC DABP
Gynecologic Pathologist, Toronto General Hospital, University Health Network
Clinician Investigator, Toronto General Hospital Research Institute
Assistant Professor, Department of Laboratory Medicine & Pathobiology
Temerty Faculty of Medicine, University of Toronto
Mansoor Raza Mirza MD
Chief Oncologist, Rigshospitalet
Medical Director, NSGO-CTU (Nordic Society of Gynaecological Oncology – Clinical Trial Unit)
Chairman, ENGOT (European Network of Gynaecological Trial groups)
Executive Director, GCIG (Gynecologic Cancer Inter-Group)
Vice-President, ESGO (European Society of Gynaecological Oncology)
Faculty, ESMO (European Society of Medical Oncology)
Mansoor Raza Mirza, MD is Chief Oncologist at the Department of Oncology, Rigshospitalet – Copenhagen University Hospital, Denmark & Medical Director of Nordic Society of Gynaecological Oncology (NSGO). He is Chair of The European Network of Gynaecological Oncological Trialist Groups (ENGOT). He is the Vice-President of European Society of Gynaecological Oncology (ESGO). He is Executive Director of GCIG, Faculty of European Society of Medical Oncology (ESMO) & European School of Oncology (ESO). He has been study chair of multiple clinical trials in gynecologic cancer for more than three decades. He is author of over 100 publications and invited speaker in most International Congresses. He is member of Board of Directors of Karyopharm Therapeutics Inc., Boston & Sera Prognostics, Salt Lake City, Utah.
Helen MacKay MBChB BSc MRCP MD
Head, Division of Medical Oncology & Malignant Hematology,
Sunnybrook Odette Cancer Centre
Senior Scientist, Sunnybrook Research Institute
Professor, Temerty Faculty of Medicine, University of Toronto
Amit Oza MBBS, MD, FRCPC
Chief, Division of Medical Oncology & Hematology, Medical Director
of the Cancer Clinical Research Unit at Princess Margaret Cancer Centre (PM)
Co-Director of the Drug Development Program at PM,
Scientist at the Ontario Cancer Institute,
Professor of Medicine University of Toronto
Kate Pulman MD FRCSC MSc
Trillium Health Partners
Assistant Professor
Gynecologic Oncologist and
Division Head of Gynecologic Oncology
Temerty Faculty of Medicine, University of Toronto